» Articles » PMID: 31131401

Cardiovascular Magnetic Resonance Techniques for Tissue Characterization After Acute Myocardial Injury

Overview
Date 2019 May 28
PMID 31131401
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The annual incidence of hospital admission for acute myocardial infarction lies between 90 and 312 per 100 000 inhabitants in Europe. Despite advances in patient care 1 year mortality after ST-segment elevation myocardial infarction (STEMI) remains around 10%. Cardiovascular magnetic resonance imaging (CMR) has emerged as a robust imaging modality for assessing patients after acute myocardial injury. In addition to accurate assessment of left ventricular ejection fraction and volumes, CMR offers the unique ability of visualization of myocardial injury through a variety of imaging techniques such as late gadolinium enhancement and T2-weighted imaging. Furthermore, new parametric mapping techniques allow accurate quantification of myocardial injury and are currently being exploited in large trials aiming to augment risk management and treatment of STEMI patients. Of interest, CMR enables the detection of microvascular injury (MVI) which occurs in approximately 40% of STEMI patients and is a major independent predictor of mortality and heart failure. In this article, we review traditional and novel CMR techniques used for myocardial tissue characterization after acute myocardial injury, including the detection and quantification of MVI. Moreover, we discuss clinical scenarios of acute myocardial injury in which the tissue characterization techniques can be applied and we provide proposed imaging protocols tailored to each scenario.

Citing Articles

Integrating angio-IMR and CMR-assessed microvascular obstruction for improved risk stratification of STEMI patients.

Duan Y, Yin Q, Yang Y, Miao H, Han S, Chi Q Sci Rep. 2025; 15(1):5470.

PMID: 39953117 PMC: 11828958. DOI: 10.1038/s41598-025-88942-0.


Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies.

Parlati A, Nardi E, Marzano F, Madaudo C, Di Santo M, Cotticelli C J Clin Med. 2025; 14(3).

PMID: 39941536 PMC: 11818251. DOI: 10.3390/jcm14030865.


Role of optical coherence tomography in clinical management of myocardial infarction with nonobstructive coronary arteries.

Tani K, Kurihara O, Shirakabe A, Kobayashi N, Takano M, Asai K J Geriatr Cardiol. 2025; 21(12):1133-1140.

PMID: 39935440 PMC: 11808491. DOI: 10.26599/1671-5411.2024.12.007.


Antibodies against angiotensin II type 1 and endothelin-1 type A receptors are associated with microvascular obstruction after revascularized ST-elevation myocardial infarction.

Civieri G, Iop L, Cozzi E, Iliceto S, Tona F Eur Heart J Open. 2024; 4(6):oeae099.

PMID: 39712648 PMC: 11660683. DOI: 10.1093/ehjopen/oeae099.


Cardiac Magnetic Resonance Imaging Findings in COVID-19: Experience from a Tertiary Care Center of North India.

Singhal M, Sharma A, Devkota S, Bhatia H, Barwad P, Otaal P Heart Views. 2024; 25(2):69-73.

PMID: 39619102 PMC: 11604198. DOI: 10.4103/heartviews.heartviews_123_23.